Add BrightSurf on Google Email

Bisphenol A and asthma in mice

Researchers found that bisphenol A (BPA) inactivates microbial lipopolysaccharides (LPS), a key trigger for allergic asthma. This disruption increases susceptibility to asthma in mice, highlighting a potential link between BPA exposure and immune disorders.

SourcePNAS Nexus·JournalPNAS Nexus·DateNov 7, 2023

A joint research team from South Korea and the United States has identified a new gene classification system for gastric cancer

A joint research team from South Korea and the US has developed a new genetic classification system for gastric cancer, identifying six consensual genomic subtypes (CGSs) with distinct characteristics. The study suggests potential treatments for each subtype, including immunotherapy and targeted therapies.

SourceKorea University College of Medicine·JournalMolecular Cancer·TypeRandomized controlled/clinical trial·DateNov 6, 2023

New antibodies neutralize resistant bacteria

Researchers have discovered highly effective antibodies against P. aeruginosa that can block its type III secretion system and are effective against highly resistant bacteria. These 'pathoblockers' offer a potential therapeutic approach for treating acute and chronic infections with multi-resistant pathogens.

SourceUniversity of Cologne·JournalCell·TypeExperimental study·DateNov 2, 2023

Breakthrough T cell discovery has huge potential for engineering custom immune responses

Researchers at Institute for Systems Biology have made a breakthrough discovery about T cells, finding that the genetically encoded T-cell receptor sequence determines a T cell's function. This fundamental discovery has huge potential for developing custom immune responses to specific antigens.

SourceInstitute for Systems Biology·JournalCell Reports·TypeRandomized controlled/clinical trial·DateOct 25, 2023

UMSOM researchers provide first statewide prevalence data on two new emerging pathogens in healthcare settings

A study by UMSOM researchers found that nearly 31% of patients on ventilators in Maryland hospitals harbored Acinetobacter baumannii, while nearly 7% carried Candida auris. The study highlights the need for improved infection control measures to contain the spread of these pathogens, which pose a significant risk to vulnerable patients.

SourceUniversity of Maryland School of Medicine·JournalJAMA·TypeObservational study·DateOct 13, 2023

New research unveils intricate mechanism behind immune system’s ability to differentiate between self and non-self antigens

A groundbreaking study sheds light on the intricate mechanism behind the immune system's ability to differentiate between self and non-self antigens. Continuous activation of self-reactive T cells is essential for maintaining equilibrium and self-tolerance through regulatory T cells.

3D genome architecture influences SCID-X1 gene therapy success

Researchers identified the integration site pattern of lentiviral gene therapies in patient cells, shedding light on treatment safety and efficacy. The study found that integration near nuclear pores is associated with improved safety and effectiveness, avoiding oncogene regions where earlier technologies failed.

SourceSt. Jude Children's Research Hospital·JournalScience Advances·TypeRandomized controlled/clinical trial·DateOct 6, 2023

Human vascular organoids reveal clues for a potential COVID treatment

Researchers have developed a human vascular organoid model that accurately mimics the damage caused by SARS-CoV-2, revealing clues for a potential COVID-19 treatment. The study identified a long-acting monoclonal antibody targeting factor D as a promising approach to mitigate severe vascular damage and thrombosis associated with COVID-19.

Allergy study on 'wild' mice challenges the hygiene hypothesis

Researchers from Karolinska Institutet challenge the hygiene hypothesis by showing that mice with high infectious exposures have a similar ability to develop allergic immune responses as laboratory mice. Despite this, they developed strong signs of pathological inflammation and allergic responses when exposed to allergens.

SourceKarolinska Institutet·JournalScience Immunology·TypeExperimental study·DateSep 29, 2023

Study finds immune cells in older adults resemble those in newborns and children, but fall short in virus detection

Research finds that immune cells in older adults are similar to those in newborns and children, but less effective at recognizing infected cells. The study, published in Nature Immunology, suggests that tailored vaccines and therapies could be developed for different age groups based on the unique characteristics of killer T cells.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalNature Immunology·TypeExperimental study·DateSep 25, 2023

Training the gut’s immune system to combat detrimental effects of emulsifiers in processed food

Researchers found that training the gut's immune system to target flagellin, a protein enabling bacterial motility, protects against emulsifier-induced chronic intestinal inflammation and metabolic dysregulation. This study suggests a potential new approach for preventing inflammatory conditions such as obesity and type 2 diabetes.

SourcePLOS·JournalPLOS Biology·TypeExperimental study·DateSep 19, 2023

Mixing donor and recipient immune systems creates tolerance of transplanted kidneys

Researchers at UW–Madison and Stanford University developed a new approach to increase donor and recipient biocompatibility, inducing tolerance in transplanted kidneys. Two monkeys with just one match among key protein strings maintained chimeric immune systems for over four years without rejection or graft-versus-host disease.

SourceUniversity of Wisconsin-Madison·JournalTransplant International·DateSep 13, 2023

Mount Sinai receives NIH grant to develop vaccines that can protect against many different types of coronaviruses

The Mount Sinai Hospital received a $13 million NIH grant to create vaccines that can protect against various types of coronaviruses. The project aims to develop variant-proof, universal vaccines that offer broad protection against existing and future SARS-CoV-2 variants, pandemic, zoonotic, and seasonal coronaviruses.

New compound unleashes the immune system on metastases

Researchers developed nanoparticles that accumulate in cancer cells and eliminate them after photoactivation, also labeling immune cells to target similar cells throughout the body. This technology has shown promise in treating mice with implanted human tumor cells and could lead to a new treatment approach for metastatic cancers.

SourceRuhr-University Bochum·JournalNature Communications·DateSep 7, 2023

3D genome analysis reveals secrets to antibody diversity

Researchers at the Babraham Institute have discovered that the 3D organisation of DNA in B cells allows for genes far away from each other to come together during antibody generation. This finding has implications for understanding why antibody diversity declines with age and suggests potential interventions.

SourceBabraham Institute·JournalCell Reports·TypeExperimental study·DateSep 7, 2023

Immune system plays vital role in longer multiple myeloma remission

Researchers found that patients' immune systems play a vital role in determining the duration of remission from multiple myeloma. Sustained minimal residual disease (MRD) negativity is associated with prolonged survival, with patients achieving MRD negativity for at least two years remaining free from multiple myeloma 10 years later.

SourceUniversity of Miami Miller School of Medicine·JournalNature Communications·DateSep 6, 2023

Network-based approaches open a new avenue to classify and treat rare diseases

Scientists at CeMM and Max Perutz Labs have reclassified approximately 200 rare immune system disorders using a network-based approach. The study reveals strong similarities between rare diseases and autoimmune conditions, enabling the prediction of treatment efficacy and personalized approaches for diagnosis and treatment.

Several vaccines associated with reduced risk of Alzheimer’s disease in adults 65 and older

Researchers found that vaccines against tetanus, diphtheria, and shingles, as well as pneumococcus, may reduce the risk of developing Alzheimer’s disease by 25-30% in adults over 65. Vaccination is hypothesized to change how the immune system responds to toxic proteins contributing to Alzheimer’s disease.

SourceUniversity of Texas Health Science Center at Houston·JournalJournal of Alzheimer’s Disease·DateAug 16, 2023